Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination. - Wikidata - wikimedia - TriplyDB

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

http://www.wikidata.org/entity/Q35130652

about

ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance?Hippo pathway mediates resistance to cytotoxic drugs.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells.Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5'-Triphosphate.In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.

P2860

Q33634888-DBBED063-5B90-46E8-BD61-9999B4A5E9ED Q34555337-2A5D0C7E-6101-458F-87F8-948D1B51C8E8 Q36342657-CB216F7A-2222-4283-B36D-55AADC4996C5 Q36844297-538AA68C-E7F7-42B5-9D58-EFB843101E33 Q37994505-56A01F96-F7D7-4C97-80FE-8798D5C539B4 Q38922511-E190139B-2923-43E0-871A-0F79984BB2C7 Q46215323-39B74C81-573E-4108-8575-D0DD0E07F310 Q47109380-B6985679-25A7-46FC-BEAA-FFCD1DFA8050 Q49387560-E25829F7-546A-41C2-B5F6-52B07DF00E0C Q55282022-6187766A-AFFB-4E28-BC7F-AD0F0004E8A3

P2860

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

http://www.wikidata.org/entity/Q35130652

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@ast

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@en

type

label

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@ast

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@en

prefLabel

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@ast

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@en

P1433

Q35130652-43D41EF5-A5F2-4474-BA13-B142DFAE0B9E

P1476

Q35130652-30096750-8726-44DC-AE1E-D8A8E0364680

P2093

Q35130652-201185FF-6CB9-4094-A66A-0D98A133CE34

Q35130652-201B3F2A-6B71-40CB-B835-5EDBB2C44043

Q35130652-63D56B69-8C12-4297-A5B6-E69CE6ABE03B

Q35130652-74FF0245-80A1-4229-AE70-F2E0295F1C20

Q35130652-8258E025-E073-477C-8829-92FD56602A07

Q35130652-8FF373D2-619F-484D-9BE5-17F4EAD3683D

Q35130652-DAF99A54-42CF-47A2-8CD2-D9699F267387

P2860

Q35130652-19135EF5-B4CC-4306-ACE4-C69EB79A7A49

Q35130652-1E8DA7EC-69A4-4D57-A75E-F0AD64AC0761

Q35130652-261A6DB8-244F-4F2F-8D6A-E5CFB514463A

Q35130652-287970F4-73CA-4B82-A0CA-A30A78DFF938

Q35130652-2CDE95C5-0FFA-446D-803C-496940DC732F

Q35130652-303E5C3A-03BB-4B2C-9A8F-DABE678DE0B1

Q35130652-3D281D2C-D75C-4FDB-87A5-EA35D8217A68

Q35130652-47DB4B63-BA1B-481D-B06B-E4C740F44531

Q35130652-4C4D660B-25DC-4247-B387-BAD75A468FF1

Q35130652-4D91E1B9-C68D-4F85-95CD-4905A6872517

P304

Q35130652-B8EDC0D1-C925-49D7-B715-93A6A9ACF6AD

P31

Q35130652-0465AE17-7E71-454B-8DC7-D8B14BACF186

P356

Q35130652-49CDBBC5-B9A4-4D3A-8C89-3062CBC47A00

P433

Q35130652-227A3D27-BF23-4D54-8A69-B1034E9884F8

P478

Q35130652-7ABD98A0-FA8F-4A8A-B69B-D04D1F00B993

P577

Q35130652-5265577B-21D8-47C5-9B8E-B4B580A58785

P5875

Q35130652-DD454896-B0BF-4BCC-9251-AB56210F1A23

P698

Q35130652-C4B60407-0B6F-48E8-A26A-797A1FB87C90

P932

Q35130652-E56AA281-0005-48FC-93F7-5223B6119A50

P356

2157-7609.1000107

P1433

Journal of drug metabolism & toxicology

P1476

Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

@en

P2093

Dan Rudin

http://www.w3.org/2001/XMLSchema#string

Judith A Gilbert

http://www.w3.org/2001/XMLSchema#string

Krishna R Kalari

http://www.w3.org/2001/XMLSchema#string

Liang Li

http://www.w3.org/2001/XMLSchema#string

Liewei Wang

http://www.w3.org/2001/XMLSchema#string

Matthew M Ames

http://www.w3.org/2001/XMLSchema#string

Nifang Niu

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers

Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap

Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.

Characterization of a side population of astrocytoma cells in response to temozolomide.

Tumor initiating potential of side population cells in human gastric cancer.

Pharmacological strategies for overcoming multidrug resistance.

Multidrug resistance transporters and modulation.

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.

Cellular pharmacology of gemcitabine.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4172/2157-7609.1000107

http://www.w3.org/2001/XMLSchema#string

P433

107

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51536198

http://www.w3.org/2001/XMLSchema#string

P698

21804948

http://www.w3.org/2001/XMLSchema#string

P932

3144579

http://www.w3.org/2001/XMLSchema#string